Literature DB >> 11475908

Potential tuberculostatic agents: micelle-forming copolymer poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid.

M Silva1, A S Lara, C Q Leite, E I Ferreira.   

Abstract

With the objective of obtaining slow-acting isoniazid derivatives, of potential use as chemoprophylactics or chemotherapeutics in tuberculosis, the micelle-forming copolymer of poly(ethylene glycol)-poly(aspartic acid) prodrug with isoniazid was synthesized. The derivative obtained was found to be active in Mycobacterium tuberculosis culture, with a minimal inhibitory concentration (MIC) 5.6 times lower than that of the tuberculostatic drug.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11475908     DOI: 10.1002/1521-4184(200106)334:6<189::aid-ardp189>3.0.co;2-6

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  4 in total

Review 1.  Prodrugs for the treatment of neglected diseases.

Authors:  Man Chin Chung; Elizabeth Igne Ferreira; Jean Leandro Santos; Jeanine Giarolla; Daniela Gonçales Rando; Adélia Emília Almeida; Priscila Longhin Bosquesi; Renato Farina Menegon; Lorena Blau
Journal:  Molecules       Date:  2007-03-19       Impact factor: 4.411

Review 2.  Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control.

Authors:  Afzal Hussain; Sima Singh; Sabya Sachi Das; Keshireddy Anjireddy; Subramanian Karpagam; Faiyaz Shakeel
Journal:  Curr Drug Deliv       Date:  2019       Impact factor: 2.565

Review 3.  In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.

Authors:  Hiraku Onishi; Yoshiharu Machida
Journal:  Molecules       Date:  2008-08-10       Impact factor: 4.411

4.  Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery.

Authors:  Franklin Afinjuomo; Thomas G Barclay; Ankit Parikh; Rosa Chung; Yunmei Song; Gayathri Nagalingam; Jamie Triccas; Lixin Wang; Liang Liu; John D Hayball; Nikolai Petrovsky; Sanjay Garg
Journal:  Pharmaceutics       Date:  2019-10-28       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.